Kontrol Technologies Delivers BioCloud Units to Belgium Hospital to Support Fourth Wave Outbreak of COVID-19

Kontrol Technologies Corp. (NEO:KNR) (OTCQB:KNRLF) (FSE:1K8) (“Kontrol” or the “Company”), a leader in smart building technology, is shipping BioCloud units to a hospital in Belgium to support a fourth wave outbreak of COVID-19. The shipment to Belgium will be applied to various areas in the hospital, with multiple applications, in support of creating safe zones.

“BioCloud continues to gain new applications and opportunities through its distribution network,” said Paul Ghezzi, CEO of Kontrol Technologies. “As the emphasis for building safety shifts to air quality and early detection systems, BioCloud is well positioned for continued adoption supported by a growing global brand awareness. I look forward to providing an update on additional testing results for BioCloud, as well as a broader update on Kontrol’s continued revenue growth and strong operational progress later this month.”

Additional Testing with Positive Detection Response to be provided November 15^th

Based on recent multiple positive detection responses by the BioCloud technology in Canada, Kontrol will provide updated testing results with associated data. The data will include the successful application of the BioCloud technology with real-time performance and results. The results will also be shared with various applicable government agencies.

Steelcase and Other Distribution Channels

Kontrol is actively quoting opportunities generated from the Steelecase partnership, in addition to other previously announced distribution partners.

International HVAC Company

Following the press released dated October 4^th, 2021, Kontrol has shipped initial units to the HVAC Company and has commenced product training while the distribution agreement continues to be negotiated. The distribution agreement is anticipated to be completed in November 2021.

About Kontrol BioCloud^TM

Kontrol BioCloud (“BioCloud”) is an operating subsidiary of Canadian public company Kontrol Technologies. The BioCloud technology is a real-time analyzer designed to detect airborne viruses and pathogens. BioCloud is an air quality technology and not a medical device. BioCloud has been designed to operate as a safe space technology by sampling the air quality continuously. With a proprietary detection chamber that can be replaced as needed, viruses are detected, and a silent notification system is created. BioCloud can be applied to any space where individuals gather including classrooms, offices, retirement homes, hospitals, mass transportation and others. Additional information about Kontrol BioCloud can be found on its website at www.kontrolbiocloud.com